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Abstract: Background: The ageing process causes a number of changes in the human immune and 
endocrine systems. The aim of this study was to assess the relationship between cognitive, emotional 
and functional skills as well lifestyle, versus selected biochemical indicators of the ageing process. 
Methods: The cross-sectional study was conducted in a group of 121 people aged 60-90 residing in 
the Lesser Poland voivodship. The study used standardized research tools including the Barthel 
scale, Instrumental Activities of Daily Living (IADL) scale, Mini-Mental State Examination (MMSE), 
Life Orientation Test (LOT-R) and inventory of health behaviors (IHB). In addition, the concentration 
of IL-6 and melatonin in the blood plasma was determined. Results: We determined the correlation 
between the level of IL-6 in a group of people over 75 years of age (requiring medical care), and results 
of the IADL scale. There was also a correlation between melatonin levels and the MMSE results in 
a group of people aged 60-75 who did not require constant medical care. Conclusions: IL-6 can 
be treated as a predictor of functional skills of people over 75 years of age, and melatonin can be 
perceived as a factor for recognizing cognitive impairment in elderly people who do not require 
constant medical assistance.
Keywords: melatonin; interleukin; ageing; functional skills; cognitive skills; emotional skills
1. Introduction
Various steps are taken to ensure that older people remain independent. Some main factors 
that affect independence include cognitive, emotional and functional skills [1,2], the lack of which
increases the sense of disability and powerlessness and increases the frequency of hospitalization and 
institutionalization into care and treatment facilities.
Human ageing is accompanied by changes in the immune system, including chronic subliminal 
inflammation which means a 2- to 4-fold increase in circulating pro-inflammatory cytokines. The most
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important of the cytokines is interleukin-6 (IL-6). It may show both pro-inflammatory properties (by 
stimulating antibody production and inducing acute inflammatory process) and anti-inflammatory 
properties (by blocking the synthesis of inflammatory cytokines) [3]. From the perspective of 
gerontology, interleukin-6 may contribute to the development of osteoporosis and induce development 
of anemia associated with chronic diseases by stimulating production of hepcidin by the liver cells. 
It is also thought to affect deposition of p-amyloid in cerebral vessels, thereby increasing the risk 
of Alzheim er's disease. One can presume that it influences the accumulation of p-amyloid in brain 
vessels, thus increasing the risk of Alzheim er's disease. Its importance in the pathophysiology of 
atherosclerosis and other cardiovascular diseases cannot be underestimated. In these patients, this is 
a risk factor for future disability development. Higher levels of IL-6 in healthy older people can be 
regarded as a marker of subclinical disease syndromes resulting in disability within a few years [3- 10].
Oxidative stress and the pineal hormone (melatonin) are associated with pathogenesis of ageing 
and diseases associated with old age [11- 17]. The ageing process is accompanied by increased 
accumulation of reactive oxygen and nitrogen (ROS: reactive oxygen species; RNS: reactive nitrogen 
species) produced in the mitochondria and lipid oxidation products (free radical ageing theory). 
Oxidative stress also accompanies many diseases including the cardiovascular system [18- 20]. It is 
currently believed that the main effect of melatonin is to protect tissues from damage by oxidative stress. 
As a lipophilic substance, it has the ability to penetrate into the cells, protecting the mitochondria and 
the intracellular structures from destruction and the cell membrane from peroxidation. The antioxidant 
activity of melatonin relies on inactivating accumulated ROS and RNS as a result of insufficient tissue 
antioxidant capacity [21]. It acts directly by neutralizing free radicals, as well as indirectly as a powerful 
activator of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) or glutathione 
peroxidase (GPx) [22,23].
Based on the division of individual stages of old age proposed by the World Health Organization 
(WHO), respondents were assigned in this study to two age groups: 60-75 years old, which is 
considered early old age (elderly people) and 76-90 years old which is called the period of old age 
(senile people) [24].
W hile designing the study, the multidisciplinary research team hypothesized based on the 
available literature that there is a relationship between melatonin and interleukin-6 levels and the 
aging process.
The main aim of the study was to assess the relationship between cognitive, emotional and 
functional skills as well as lifestyle, and selected biochemical indicators of the ageing process in elderly 
people (60-75 years old) and senile people (76-90 years old).
The following specific objectives were identified in the study:
1. Assessment of the relationship between cognitive, emotional and functional skills and lifestyle 
versus the level of the hormone melatonin in elderly people and senile people.
2. Assessment of the relationship between cognitive, emotional and functional skills and lifestyle 
versus the level of pro-inflammatory cytokine interleukin-6 (IL-6) in elderly people and 
senile people.
2. Materials and Methods
2.1. Study Design
The cross-sectional study was conducted between 2018 and 2019, in a group of 121 people after 
obtaining the consent of 10 managers of facilities located in the lesser Poland voivodship. In 2018, 
funds were obtained under the statutory project number N43/DBS/000060. The facilities which 
participated in the study provided services and support to elderly and senile people which included 
care and treatment institutions (ZOL), daily houses of healthcare (DDOM), municipal daily houses of 
social care (MDDPS), senior activity centers (CAS) and activation clubs for seniors (KAS). The survey 
study combined with biochemical blood analysis presented in this paper consisted of four stages: (1)
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information, (2) interview with the study participant, (3) complementing the research tools with the 
study participant, (4) blood collection of the study participant. It was conducted by a multidisciplinary 
team of research and development staff (nurses, a laboratory worker a psychologist).
2.2. Procedure
The following criteria was required for inclusion in the study: (1) written consent to participate 
in the study, (2) absence of mental illness, Alzheim er's disease or other severe neurodegenerative 
diseases, (3) absence of terminal cancer, (4) absence of visible infection features such as pneumonia and 
throat inflammation, (5) adequate preparation for the blood test which required 6-8 h of fasting and (6) 
no melatonin supplements. The participants of the study were provided with all necessary information 
about it, and were informed about the purpose of the study, voluntary participation in it, and the 
possibility of withdrawal at every stage of its conduct. Participants were not selected for convenience 
or through the user lists. Targeted selection of participants was used in the study. Potential participants 
were selected in consultation with the facility managers. The main criterion was informed consent to 
participate in the study, which was associated with absence of mental illness, Alzheimer's disease or 
other severe neurodegenerative diseases which make it difficult to make an informed decision.
2.3. Ethical Considerations
The study was carried out after obtaining confirmation from the Bioethical Committee (Opinion 
No. 1072.6120.205.2018 of 20 September 2018). It was conducted and developed in accordance with the 
principles of good scientific practice, the Act of 10 May 2018 on the protection of personal data and 
the principles of the Helsinki Declaration. It was also carried out in accordance with the Regulation 
(EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of 
natural persons with regard to the processing of personal data and on the free movement of such data, 
and repealing Directive 95/46/EC (General Data Protection Regulation) [25,26].
2.4. Sampling
Data from the Central Statistical Office of Poland indicate that the number of old people (65+) in 
the lesser Poland voivodship in 2018 was 680,178 people [27] . Therefore, respondents participating in 
the study constituted 0.02% of the reference population. Analyzing the data only for the city of Krakow 
(from which over 80% of respondents came from), it can be seen that in 2018 the number of senile 
people registered in the city was 183,036. Therefore, the group participating in the survey constituted 
approximately 0.07% of the population of people over 65 in Krakow [28].
The study group (SG) consisted of women and men in elderly in two age groups (60-75 years 
old and 76-90 years old). These people underwent inpatient care in a care and treatment institution 
(ZOL) and temporarily in the daily houses of healthcare (DDOM) and required medical care. A total of 
66 people met the inclusion criteria.
The elderly and senile women and men who lived at home, were active and benefited from the 
services of the MDDPS, CAS and KAS were in the comparative group (CG). There were 55 respondents 
in total in this group. The people who met the previously mentioned inclusion criteria did not require 
inpatient medical care.
The sociodemographic characteristics of the SG and CG are presented in Table 1 .
Table 1. The comparison of study participants in terms of sociodemographic variables.
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Parameters
The Study Group 
(N =  66)
n/%
The Comparative Group 
(N =  55)
n/%
P *
Female 48/72.73 49/89.09 p =  0.044
Gender Male 18/27.27 6/10.91
60-65 years old 3/4.55 17/30.91 p <  0.001
66-70 years old 13/19.70 16/29.09
71-75 years old 6 9.09 11/20.00
Age 76-80 years old 15/22.73 3/5.45
81-85 years old 15/22.73 6/10.91
86-90 years old 11/16.67 2/3.64
Over 90 years old 3/4.55 0/0.00
Village 5/7.58 5/9.09 p =  0.639
Town (<50 thousand people) 1/1.52 0/0.00
Places of residence Town (50-100 thousand people) 3/4.55 5/9.09
Big city (>100 thousand people) 57/86.36 45/81.82
* Chi-square test/Fisher's exact test. The comparison of values of qualitative variables in the groups was made using 
the chi-square test (with Yates correction for 2 x 2 tables) or Fisher's exact test where the low expected numbers 
appeared in the tables. The statistical value is p.
2.5. Methods, Techniques and Research Tools
The study used the following research methods: (1) estimation method with standardized research 
tools in the form of test scales, (2) diagnostic survey method in the form of metrics and interviews, 
(3) statistical methods including techniques for measuring central tendency, measures of variability 
and statistical tests, (4) blood biochemistry by assessing interleukin-6 and melatonin in the venous 
plasma and (5) analysis of medical documentation available in medical facilities study to determine 
coexisting diseases.
Assessment of each patient in terms of functional skills took place on the basis of selected test scales. 
To assess skills in basic everyday activities (e.g., eating, moving, maintaining personal hygiene, using the 
toilet, bathing, dressing, going up and down the stairs) the Barthel scale (Barthel index) was used. According 
to this scale, the respondents were divided into three groups. The first group consisted of people who were 
defined as having a mild health condition or good functional condition (86-100 points). The second group 
has a medium level of health conditions/functional impairments (21-85 points) and the third group was 
defined as having a severe health condition/disability (0-20 points) [29- 32].
To assess complex daily activities (instrumental functioning), Lawton's Instrumental Activities of 
Daily Living (IADL) scale was used [29,33]. This made it possible to evaluate activities such as using 
the telephone, shopping, doing housework, cleaning and managing money.
Another research tool applied to assess the cognitive skills (cognitive function) of the older 
people was the Mini Mental State Examination (MMSE), which was developed by M.F. Folstein, S.E. 
Folstein and G. Fanjang. The tool was adapted to Polish conditions by J. Stańczak. MMSE assesses 
basic cognitive functions [34,35] and is a standardized research tool employed to screen dementia 
changes, while simultaneously assessing memory, counting, attention, concentration, visual-spatial 
coordination, orientation and language functions.
In this study, the Life Orientation Test (LOT-R) [36] was also implemented which was developed by 
M.F. Scheier, Ch. S. Carver and M.W. Bridges. R. Poprawa and Z. Juczyinski carried out the adaptation 
of the research tool to Polish conditions. The LOT-R measures available optimism. One should note 
that optimistic people use emotion-based strategies such as acceptance or sense of humor more often 
in problematic situations [37,38]. Optimism is often treated as one of the most important personal 
resources conditioning hum an's physical and psychological well-being. Therefore, it was used as 
a component in this study to analyze the assessment of emotional skills of older people.
The last standardized research tool used in the study was inventory of health behaviors (IHB) [36] 
developed by Z. Juczyfrski, which was applied to assess the lifestyle of older people. This research 
tool allowed us to measure the overall indicator of the intensity of health behavior. It consists of 
24 statements that relate to a variety of health-related behaviors. This inventory is used to assess
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the intensity of preventive behaviors, proper eating habits and health practices, as well as positive 
mental attitudes.
The brief demographic questionnaire attached to the survey was specially developed for the 
study and allowed for gathering of information on sociodemographic variables such as age, gender, 
place of residence and coexisting diseases. The latter data was also confirmed during the analysis of 
medical documentation.
The study participants independently filled in three research tools (IADL, LOT-R and the brief 
demographic questionnaire). While completing the other two standardized research tools (MMSE 
and the Barthel scale), a member of the research team was present and asked questions to the subject. 
The MMSE and the Barthel scale are tools completed by a person with medical/ psychological education. 
The participant cannot objectively fill these tools in on their own.
2.6. Biochemical Blood Test
The collection of 5 m L of venous blood in vacuum tubes to determine the concentration of 
interleukin-6 (IL-6) and melatonin in plasma was one of the stages of the study. Venous blood was 
collected from each participant in the morning. Each tube contained K3EDTA (1.6 mg/mL blood) along 
with aprotinin (50 KIU/mL blood), which is an inhibitor of proteolytic enzymes. After thoroughly 
mixing the tubes, the collected material was placed in a centrifuge and centrifuged for 10 min at a speed 
of 3500 revolutions per minute (rpm). The centrifuged plasma was put in Eppendorfs (1.5 mL) and 
frozen at a temperature of -8 0  °C. The plasma was also stored at this temperature. After collection of 
the appropriate number of blood samples from participants, the tests were performed free of charge 
using commercial kits in a medical laboratory located at the University. The determinations were made 
on samples without hemolysis and lipemia. All measurements were carried out in accordance with the 
instructions of the manufacturer of the laboratory kits used in the study. Blood tests were performed 
by enzyme immunoassay method.
During the blood test, all precautions were taken and the principles of aseptic and antiseptic were 
followed. The study participants received details about the correct procedure after blood was taken. 
The subjects had the opportunity to become familiar with the results of the blood tests. Additional 
information was provided that the test results may be intended for research use only and not for use in 
diagnostic procedures.
2.7. Statistical Analysis
The study applied the following statistical methods: Chi-square test, Fisher's exact test, 
M ann-W hitney U-test and Spearman rank correlation coefficient. The comparison of the values of 
qualitative variables in the groups was made implementing the Chi-square test (with Yates correction) 
or Fisher's exact test where the low expected numbers appeared in the tables. The comparison 
of quantitative variable values in two groups was performed using the M ann-W hitney U-test. 
The correlations between quantitative variables were analyzed using the Spearman rank correlation 
coefficient. The analysis assumed the significance level a =  0.05. The collected research material was 
prepared in the R program, version 3.6.1 [39].
3. Results
The article shows statistically significant differences between the study and comparative groups. 
The study group had a smaller percentage of women and the respondents were older (Table 1).
People living at home, actively participating in classes organized by MDDPS, CAS and KAS 
(belonging to the comparative group) had better functional skills during basic daily activities which 
was indicated by a higher score on the Barthel scale. They also showed greater efficiency during the 
performance of complex daily activities, which was indicated by higher results obtained from the IADL 
scale, and also presented greater efficiency in the field of cognitive ability (shown with higher MMSE 
results) compared to the people in the study group. In addition, the respondents from the CG had
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more intense health behaviors and higher results in individual subscales of the IHB, including proper 
eating habits, preventive behaviors and a positive mental attitude compared to people undergoing 
inpatient care in ZOL and those in DDOM who required medical care (Table 2).
Table 2. The com parison of study participants in terms of functional, cognitive and emotional skills 
and lifestyle using standardized research tools.
Research Tools Study Group (N =  66)
Comparative Group 
(N =  55) p *
Barthel scale
X ± SD 
Me 
quartiles
40.3 ± 29.39 
35 
20-40





X ± SD 
Me 
quartiles
14.71 ± 4.37 
13 
12-17





X ± SD 
Me 
quartiles
22.74 ± 3.35 
22 
20-25





X ± SD 
Me 
quartiles
14.76 ± 5.31 
14 
12-19




Total score of IHB
X ± SD 
Me 
quartiles
86.03 ± 16.93 
89.5 
75.5-98.75




IHB: Proper eating habits
X ± SD 
Me 
quartiles
3.33 ± 0.96 
3.5 
2.5-4





X ± SD 
Me 
quartiles
3.43 ± 0.8 
3.5 
3-4




IHB: Positive mental 
attitude
X ± SD 
Me 
quartiles
3.66 ± 0.89 
3.83 
3.04-4.33





X ± SD 
Me 
quartiles
3.91 ± 0.7 
4
3.67-4.33




*, Mann-Whitney U-test. X, mean; SD, standard deviation; Me, median; p, statistical value.
After analyzing the results of blood tests, it can be stated that in the study group the average 
level of melatonin was 436.85 ng/L, while in the comparative group the average was slightly higher 
(471.24 ng/L). The average concentration of interleukin-6 in the blood plasma of the study group was 
22.29 pg/L and in the comparative group it was 17.07 pg/L. It should be noted that these groups did 
not differ significantly in the level of proinflammatory cytokine-interleukin-6 or the level of melatonin, 
which was demonstrated in our statistical analysis (p >  0.05) (Table 3).
The analysis of the Barthel scale results showed that in the study group the largest one consisted of 
people whose functional status could be defined as "medium level" (33 respondents, 50%) while in the 
comparative group, the vast majority were people whose functional status could be defined as "m ild" 
(54 respondents, 98.18%). Most of the people in the study group presented cognitive impairment 
or reduced performance in the field of mental ability (55 of the people surveyed, 83.33%). In the 
comparative group, the majority of individuals who were evaluated had cognitive skills that were 
considered correct (39 people, 70.91%). It should be noted that in the study group the largest percentage 
of respondents were those with a high level of dispositional optimism—in other words, a high level of 
emotional skills (29 respondents, 43.94%). The comparative group was dominated by people with 
an average level of dispositional optimism (24 respondents, 43.64%). In both the study and comparative
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groups, the highest percentage were those with a high intensity rate of health behaviors (SG, 33 people, 
50.00%; CG, 37 people, 67.27%) (Table 4).
Table 3. The comparison of study participants in terms of interleukin-6 and melatonin values.
Parameters
Study Group 
(N =  66)
Comparative Group 
(N =  55)
p *
Interleukin-6 [pg/L]
X ±  SD 22.29 ±  36.52 
Me 9.86 
quartiles 5.43-20.11
17.07 ±  24.16 
8.24 
3.38-20.32
p =  0.284
Melatonin [ng/L]
X ±  SD 436.85 ±  336.05 
Me 319.75 
quartiles 225.48-543.09
471.24 ±  364.67 
308.62 
212.28-675.26
p =  0.893
*, Mann-Whitney U-test; X, mean; SD, standard deviation; Me, median; p, statistical value.
Table 4. Functional, cognitive and emotional skills and lifestyle of participants from the study and 
comparative group.
Research Tools/Parameters
Study Group Comparative Group 
(N =  66) (N =  55)
n/% n/%
Barthel scale
"Severe" health condition 









No cognitive impairment 
Cognitive impairment without 
dementia 



























The statistical analysis did not show any relationship between the level of interleukin-6 and 
melatonin versus functional, cognitive and emotional skills and the degree of health behavior intensity 
(results from standardized tools) among elderly respondents (60-75 years) belonging to the study 
group who were undergoing inpatient care in ZOL and DDOM (Table 5).
There was a relationship between the level of melatonin in elderly people (60-75 years) belonging 
to the control group and the results obtained from the MMSE scale. In the group of older people 
showing activity in everyday life, the MMSE scale results correlated significantly (p <  0.05) and 
negatively with the level of melatonin. In other words, the higher the level of this hormone, the lower 
the MMSE score (poorer cognitive skills). The relationship between the level of interleukin-6 and 
functional, cognitive and emotional skills and intensity of health behaviors was not found in the 
comparative group (Table 6).
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Table 5. The relationship betw een the level of interleukin-6 and m elatonin and the results obtained 
from standardized research tools among respondents aged 60-75 belonging to the study group (n =  66).
Correlation (Spearm an Rank Coefficient)
Interleukin-6 M elatonin
Barthel scale 0.292 p =  0.188 0.059 p =  0.805
IADL 0.245 p =  0.272 0.115 p =  0.631
MMSE -0 .142 p =  0.527 -0 .166 p =  0.485
LOT-R -0 .113 p =  0.618 -0 .186 p =  0.433
Total score of IHB 0.26 p =  0.242 -0 .087 p =  0.716
IHB: Proper eating habits 0.147 p =  0.515 0.131 p =  0.581
IHB: Preventive behaviors 0.099 p =  0.66 -0 .063 p =  0.793
IHB: Positive mental attitude 0.111 p =  0.623 -0 .176 p =  0.459
IHB: Health practices 0.251 p =  0.259 -0 .090 p =  0.705
Table 6. The relationship betw een the level of interleukin-6 and m elatonin and the results obtained 
from standardized research tools among respondents aged 60-75 belonging to the comparative group 
(n =  55).
Correlation (Spearm an Rank Coefficient)
Interleukin-6 M elatonin
Barthel scale -0 .124 p =  0.424 -0 .205 p =  0.205
IADL 0.06 p =  0.697 -0 .227 p =  0.160
MMSE -0 .089 p =  0.564 -0 .328 p =  0.039
LOT-R 0.258 p =  0.091 -0 .255 p =  0.113
Total score of IHB -0.081 p =  0.599 -0 .096 p =  0.558
IHB: Proper eating habits -0 .124 p =  0.424 -0 .025 p =  0.876
IHB: Preventive behaviors 0.149 p =  0.333 -0 .282 p =  0.077
IHB: Positive mental attitude -0 .048 p =  0.758 -0 .011 p =  0.945
IHB: Health practices -0 .165 p =  0.285 -0 .008 p =  0.960
A relationship between the level of interleukin-6 and melatonin in senile patients from the SG 
and the results obtained from the IADL scale and IHB was found. The IADL results correlated 
significantly (p < 0.05) and negatively with the level of interleukin-6, which meant that the higher the 
pro-inflammatory cytokine level, the lower the functional skills in performing complex daily activities 
(lower IADL results) were. It should be noted that the results of the subscale of proper eating habits 
correlated significantly (p < 0.05) and negatively with the level of melatonin. Higher levels of melatonin 
correlated with less proper eating habits in the group of people over 75 years old (Table 7).
The statistical analysis showed the relationship between the level of interleukin-6 and melatonin 
of people over 75 years of age belonging to the CG, and the results of the IADL scale, Barthel scale and 
LOT-R scale. The IADL scale results correlated significantly (p <  0.05) and negatively with the level 
of interleukin-6. The higher the level of this cytokine, the lower the functional skills in performing 
complex daily activities in a group of people using various forms of activity. The results of the Barthel 
scale, IADL scale and LOT-R scale correlated significantly (p <  0.05) and positively with the level of 
melatonin. The higher the level of this hormone, the better the functional skills (higher results of the 
Barthel scale), the greater the efficiency in performing complex daily activities (higher IADL scale 
results) and the greater the tendency for optimism (higher LOT-R scale results) (Table 8).
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Table 7. The relationship between the level of interleukin-6 and melatonin and the results obtained from 
standardized research tools among respondents over 75 years old belonging to the study group (n =  66).
Correlation (Spearm an Rank Coefficient)
Interleukin-6 M elatonin
Barthel scale -0 .183 p =  0.235 -0 .118 p =  0.463
IADL -0.331 p =  0.028 -0 .042 p =  0.795
MMSE -0 .202 p =  0.187 -0 .275 p =  0.082
LOT-R -0 .154 p =  0.319 -0 .014 p =  0.929
Total score of IHB -0 .033 p =  0.832 -0 .276 p =  0.081
IHB: Proper eating habits 0.085 p =  0.582 -0 .373 p =  0.016
IHB: Preventive behaviors -0 .0 2 7 p =  0.863 -0 .246 p =  0.121
IHB: Positive mental attitude -0 .108 p =  0.485 -0 .054 p =  0.738
IHB: Health practices -0 .082 p =  0.596 -0 .146 p =  0.363
Table 8. The relationship betw een the level of interleukin-6 and m elatonin and the results obtained 
from standardized research tools among respondents over 75 years old belonging to the comparative 
group (n =  55).
Correlation (Spearm an Rank Coefficient)
Interleukin-6 M elatonin
Barthel scale -0 .306 p =  0.359 0.663 p =  0.026
IADL -0 .724 p =  0.012 0.613 p =  0.045
MMSE 0.433 p =  0.183 0.284 p =  0.398
LOT-R -0 .035 p =  0.919 0.651 p =  0.030
Total score of IHB -0 .174 p =  0.610 0.064 p =  0.852
IHB: Proper eating habits -0 .461 p =  0.154 -0 .181 p =  0.594
IHB: Preventive behaviors -0 .253 p =  0.452 -0 .110 p =  0.747
IHB: Positive mental attitude 0.266 p =  0.429 0.476 p =  0.139
IHB: Health practices -0 .169 p =  0.619 0.224 p =  0.508
4. Discussion
Currently, in Poland and other European Union countries, the rapidly ageing population is being 
observed, which is largely associated with the extension of life expectancy and low fertility levels. 
The United Nations (UN) predicts that by 2030 the proportion of older people (over 65 years old) in 
Europe will be 23.8%. There are already several countries where there is a high percentage of people 
aged 65 years old and over, including Germany, Italy and Greece. It should be noted that Poland 
is also struggling with the problem of an ageing society because older people (65+) in our country 
constitute over 15% of the general population [40- 42]. Analyzing the report published by the Central 
Statistical Office (CSO) presenting the population forecast for 2008-2035, it can be seen that in 2035 it 
is estimated that people aged 65 and over will make up 23.2% of the population, people 75 years 
and older will make up 12.2% of the population, and people 85 and older will make up 3.1% of the 
population, relative to the population as a whole [41]. This situation will force changes not only in the 
socioeconomic sector, but it will also mobilize health care sector representatives to implement activities 
aimed at obtaining new information on the functioning of the human body and changes that take 
place in it over the years. The aim of the study was to provide information on the biochemical factors 
determining the reduction of physical, mental and emotional skills of the elderly and senile, which can 
be used in the process of planning preventive measures to improve the quality of life of older people.
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Analyzing the available literature, it can be stated that the ageing process of the body is associated 
with a number of changes in the systems of the body, including the immune system (increased 
concentration of proinflammatory cytokines such as interleukin-6) and the hormonal system (such as 
a decrease in melatonin levels) [5,7].
During the conducted research, the multidisciplinary research team sought to verify the 
truthfulness of the research hypothesis, which assumes the existence of a relationship between 
melatonin and interleukin-6 and the aging process.
The analysis did not show any relationship between the level of melatonin and interleukin-6 versus 
functional, cognitive and emotional skills or degree of health behaviors intensity among respondents 
aged 60-75 years who needed medical attention. It should be emphasized that the study showed 
a relationship between melatonin levels among people aged 60-75 years old who were active in 
everyday life and did not require inpatient medical care. Higher levels of melatonin were associated 
with poorer cognitive skills. It should be noted that in this group, no relationship between the level of 
interleukin-6 and functional, cognitive and emotional skills or degree of health behaviors intensity 
was found.
In a group of people over 75 years old the situation was different. The higher the pro-inflammatory 
cytokine level (interleukin-6), the lower the functional skills in performing complex daily activities, 
while the higher the level of melatonin. The eating habits were also less proper in the group of people 
over 75 years old who required medical care.
In a group of people over 75 years old who were active and who did not require hospitalization or 
medical care, a higher level of interleukin-6 determined lower functional skills in performing complex 
daily activities. In turn, one can associate higher levels of melatonin with better functional skills and 
a greater tendency to optimism.
As the obtained results show, it is difficult to state unequivocally what effect melatonin and 
interleukin-6 levels have on the aging process. Therefore, further research and complex analyses 
are necessary.
In this study, the study group and the comparative group did not differ significantly in their 
levels of interleukin-6 and melatonin. This study did not confirm the scientific reports that higher IL-6 
levels in "healthy" older people can be treated as a marker of subclinical disease syndromes, leading to 
disability within a few years [4- 9]. It should be noted that further research is needed to address this 
issue on a much larger study sample.
Previous studies, both cross-sectional and longitudinal, showed that higher levels of inflammatory 
cytokines are associated with a decrease in cognitive function [43- 49]. The relationship between higher 
levels of IL-6 and increased risk of dementia was presented in a meta-analysis [50]. However, this was 
not clearly demonstrated in another study [51]. It was similar to a population clinical study about ageing 
(Mayo Clinic Study of Aging, MCSA) and multivariate analyses. They examined the cross-sectional 
and longitudinal associations between baseline-measured IL-6, IL-10, and tumor necrosis factor (TNFa) 
levels in the blood and the ratio of IL-6/IL-10 with cognitive test performance and mild cognitive 
impairment. There were 1602 elderly people in the studied community (median age =  72.8). The IL-6 
to IL-10 ratio is considered a marker of the function of the congenital immune system [52] . In our 
study, there was no relationship between IL-6 level and cognitive skills of elderly people (60-75 years 
old) and senile people (over 75 years old) in the study group and comparative group. The results 
presented in this article are therefore similar to the results obtained by other authors [51,52]. A possible 
explanation for our observed lack of association between the inflammatory cytokine and cognitive 
skills can be the fact that the test was carried out only once. In the longer term studies, inflammatory 
cytokines were associated with poor cognitive skills. It is still possible that high levels of inflammatory 
cytokines are associated with a decrease in cognitive/mental function (MMSE scale) over longer periods 
of study. It should be noted that the present study also showed no significant relationship between the 
level of IL-6 in the study and comparative groups (65-75 years), functional skills (Barthel scale scores 
and IADL scale scores), emotional skills (LOT-R scores) or the intensity of health behavior (results of
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IHB). However, in the group of senile people, there was a correlation between the pro-inflammatory 
cytokine levels and functional skills. It has been shown that the higher the IL-6 level, the lower the 
efficiency in performing complex daily activities such as cleaning and shopping, both in the study and 
comparative groups. It is worth noticing that chronic inflammation can affect the loss of physical skills 
in older people or significantly reduce them, which leads to disability in the field of daily activities. 
These results are consistent with the results of another study in which two-dimensional analysis 
showed significantly higher levels of IL-6 in people with lower results on the ADL scale which assesses 
basic daily activities [53]. Also, a study conducted among 1020 participants (aged 65 and over) showed 
a significant relationship between inflammation (high levels of IL-6, CRP and IL-1RA) versus poor 
physical performance and muscle strength [54]. With age, the level of circulating pro-inflammatory 
cytokine increases, which contributes to a decrease in muscle strength which can significantly affect 
the efficiency of the human body [55]. This shows that the assessment of inflammatory markers can 
become a key screening test to assess the functional capacity of elderly and senile people.
Sleep disorders are a common problem among older people. Insomnia can negatively affect the 
physical and mental state of older people, and thus negatively affect their functioning in everyday life. 
Circadian disturbances in melatonin secretion may contribute to accelerated ageing. Oxidative stress 
and inflammation predispose people to loss of muscle strength, and thus to functional limitations and 
disabilities [56,57]. It has been shown that, apart from the pineal gland, melatonin receptors occur 
in the central nervous system, retina, heart, blood vessels and cells of the immune system as well as 
in the stomach, pancreas and small intestine [58,59]. It must be said that the level of this hormone 
decreases with age, and its circadian rhythm disappears in the elderly [60].
In the present study, no relationship between the level of melatonin versus functional, cognitive 
and emotional skills or intensity of health behaviors in the group of elderly people residing in ZOL or 
DDOM requiring medical support was found. Similar results were obtained in another study which 
assessed urinary melatonin levels in relation to cognitive function, physical fitness and mortality 
among 2821 older men [61]. There was no relationship between this hormone and these variables. 
It should be noted that our study showed a relationship between melatonin levels in elderly people 
(60-75 years old) from the comparative group and cognitive skills (MMSE scores). Higher levels of this 
hormone correlated with worse cognitive skills. The results obtained are inconsistent with the results 
of the study conducted among 1105 elderly people, where higher melatonin levels were associated 
with a lower frequency of cognitive impairment and depressed mood [62]. Possible discrepancies may 
result from the fact that in the above study, melatonin levels were assessed in urine samples whereas 
in the present study we used a venous plasma test. A meta-analysis of three randomized controlled 
trials also showed a negligible effect of melatonin supplementation on cognitive function, which was 
assessed using the MMSE scale [63].
In the present study, the relationship between melatonin levels in the senile belonging to the 
study group and the results of the subscale of proper eating habits was noticed. The higher the level 
of hormone produced by the pineal gland, the less proper the eating habits in this group of older 
people were. It should also be added that we found a relationship between the level of melatonin 
and the functional and emotional skills of people who were more than 75 years old belonging to the 
comparative group (people were more active and used the services of CAS and KAS). Higher levels of 
the hormone correlated with greater functional skills (IADL scores, Barthel scale scores) and a greater 
propensity for optimism (higher LOT-R scores). These results are similar to other studies which 
demonstrated a relationship between physiological levels of melatonin and mood [62]. A higher level 
of the hormone produced by the pineal gland was associated with lower prevalence of depressed 
mood among older people.
This study has many strengths, including population sample, a study and a comparative group, 
cross-sectional study structure and a high, sensitive measurement of inflammatory cytokine and 
melatonin in the venous plasma. Although the research provided important information about 
cognitive, emotional and functional skills of older people from a large Polish urban agglomeration,
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it has several limitations. One of them is a relatively small sample size, which was not representative. 
The conclusions cannot be generalized to the general population of older people but only this study 
sample. The study used targeted selection of participants, but it did not use a program to calculate 
sample size. Moreover, the age and gender of study and comparative groups was not homogeneous 
which may be a bias. These elements have been included as limitations of the study. It is our hope 
that the obtained results and conclusions will encourage others to explore the issues of subclinical 
markers of disease syndromes and holistic geriatric assessment using scales and tests assessing 
cognitive, functional and emotional skills. We also hope this study will be used in the development 
and implementation of new, effective disease diagnostic methods for the elderly in order to improve 
medical care for this special group of patients.
The obtained results may contribute to the development of a standard geriatric assessment scheme, 
with particular emphasis on biochemical indicators of the aging process. In clinical practice this will 
allow for rapid diagnosis of age-related pathologies, implementation of preventive and educational 
actions, and holistic medical care for older people.
5. Conclusions
The results of the research indicate that:
1. The inflammatory marker IL-6 in blood plasma may not be useful in determining cognitive 
and emotional skills impairment or the intensity of health behaviors among elderly people 
(60-75 years), both active and requiring constant medical care. It can be partially treated as 
a predictive factor of functional skills, especially for people over 75 years of age.
2. Melatonin can be used in the process of recognizing cognitive skill impairment in elderly people 
(60-75 years of age) who do not require constant medical care. It can also be used to recognize the 
functional and emotional skill impairment in senile people who are active and do not require 
hospitalization or medical support.
3. There is a need for further research among older people in more centers in Poland. It also seems 
extremely important to pay attention to cultural diversity and diet, as well as intensity and type 
of physical activity of the surveyed people in the future.
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